Mycobacterial Infections Flashcards
TB Pathogenesis
Bacilli reach alveolar space
Proliferation inside macrophages
Initial inflammatory granulomatous tubercle formation (if controlled here=latent infection)
Enlargement of tubercle and infiltration of lymph system (Gohn complex)
Secondary/Reactivation Presents with
Cough, hemoptysis Persistent fever/night sweats Weight loss Malaise Adenopathy Pleuritic chest pain
Miliary Tuberculosis
denote ALL forms of progressive, widely disseminated hematogenous tuberculosis, even if the classical pathologic or radiologic findings are absent.
Tuberculin Skin Testing
Positive tuberculin skin test does NOT by itself prove the presence of active disease but DOES indicate that infection has occurred
Primary use is in detection of Latent TB Infection
MUST be read at 48-72 hours
Test is read by the diameter of the induration, NOT the diameter of erythema
If patient is being tested shortly after exposure, repeat testing should be done in 6-12 weeks
An induration of ≥ 5 mm
HIV positive persons
Recent contacts of TB case
Fibrotic changes on chest radiograph consistent with old TB
Patients with organ transplants and other immunosuppressed patients (Prednisone)
An induration of ≥ 10 mm
Recent arrivals (<4 yr of age or infants, children, and adolescents exposed to adults in high-risk categories
An induration of ≥ 15 mm
Persons with no risk factors for TB
Mycobacterium Culturing
Gold standard for the diagnosis of tuberculosis
organism has slow growth rate
Whole-blood interferon-gamma assay (e.g. QuantiFERON-TB Gold test)
Screening test for asymptomatic disease
Rapid Nucleic Acid Assays
Can produce results within two to seven hours after sputum processing
generally recommended on all AFB smear-positive respiratory specimens
Latent Tuberculosis Management
Generally the recommendation is nine months of Isoniazid (INH) monotherapy
Reactivation TB Disease Management
Requires at least 2 effective drugs Several guidelines recommend that initial therapy of active tuberculosis is four drugs: Isoniazid (INH) Rifampin (RIF) Pyrazinamide (PZA) and Ethambutol (EMB)
Isoniazid (INH)
MOA: Covalently binds to and inhibits enzymes essential for the synthesis of mycolic acid (key component of the cell wall)Hepatotoxicity, must monitor liver enzymes
***Most common side effect is peripheral neuritis which manifests as paresthesias and is associated with pyridoxine (vitamin B6) deficiency
Rifampin (RIF)
MOA: Blocks transcription by interfering with the beta subunit of bacterial RNA polymerase
Hepatotoxicity, liver enzymes
Inducer of cytochrome P450
Pyrazinamide (PZA)
Only seen in antitubercular combo packages
Extensively metabolized by the liver, must watch for hepatotoxicity!
Gout